NDC 63323-351
Rifampin 600 mg injection, powder, lyophilized, for solution
On the label: Fresenius Kabi, LLC.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Fresenius Kabi USA, LLC | Melrose Park, IL, United States | Makes it and tests it | Problems found, fixed voluntarilyAug 24, 2023 · 13 inspections, 2 with FDA action |
Recalls
- Jun 4, 2015 · Class II · Fresenius Kabi USA, LLC
Failed Impurities/Degradation Specifications; out-of-specification for color, impurity, and degradation
Lots: Lot #: 6109469, 6109470, Exp 10/2016
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Rifampin: every company that makes it
- Form
- injection, powder, lyophilized, for solution, intravenous
- Strength
- 600 mg
- Approval
- ANDA ANDA091181
- On the market since
- Aug 21, 2014
- Package NDCs
63323-351-20- Official label
- DailyMed (National Library of Medicine), updated Aug 29, 2022
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?